Cordis (medical)

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cordis Corporation
Founded 1957 (as The Medical Development Corporation)
Founder Dr. William P. Murphy Jr.
Headquarters Fremont, California, U.S.
Area served
Worldwide
Products Medical devices
Website Cordis.com

Cordis Corporation develops and manufacturers diagnostic and interventional products to treat patients who suffer from coronary and peripheral vascular diseases. It was founded in 1959 in Miami, Florida. Cordis Corporation is a company of Cardinal Health. The Cordis global headquarters and a Europe, Middle East and Africa hub are located in Zug, Switzerland. North American operations are based out of the San Francisco Bay area. The Asia-Pacific hub is located in Singapore, and the Latin American hub is located in Puerto Rico.[1]

History[edit]

The Medical Development Corporation was founded in 1957 in Miami, Florida, by Dr. William P. Murphy Jr. and focused on interventional vascular medicine and neuroscience. In 1959 the company’s name changed to Cordis. Cordis joined the Johnson & Johnson interventional business called “Johnson & Johnson Intervention Systems (JJIS)” and forms Cordis Corporation in 1996. In 1997 Cordis Corporation expanded into the rapidly growing field of electrophysiology through the acquisition of Biosense Inc. One year later, in 1998, Biosense Inc. merged with Webster Laboratories to form Biosense Webster, Inc.

On October 4, 2015, Cardinal Health announced that it has completed the acquisition of Johnson & Johnson's Cordis business for $1.944 billion.[2]

Product categories[edit]

Cardiology products[edit]

Endovascular products[edit]

Headquarters[edit]

Corporate Headquarters:
Cordis Corporation
6500 Paseo Padre Pkwy
Fremont, CA 94555, U.S.

Europe, Middle East and Africa Regional Headquarters:
Cordis, a Division of Johnson & Johnson Medical N.V.
Leonardo Da Vincilaan 15
Diegem, Belgium

External links[edit]

References[edit]